In an administration where appointees have often been known for anti-regulatory actions, Dr. Gottlieb has stood out as particularly adept in issuing new rules—and sometimes being willing to take stances critical of companies being regulated.
Trending:
WSJ: FDA Commissioner Scott Gottlieb to leave the agency